The following is excerpted from the question-and-answer section of the transcript.
(Questions from industry analysts are provided in full, but answers are omitted - download the transcript to see the full question-and-answer session)
Question: Josh Jennings - TD Securities LLC - Analyst
: Thanks, Heather. That was a fantastic download and got an incredible pipeline and a huge opportunity in front of you and your team. I was hoping
just to better understand, I'm just looking at the one slide where you describe the development and the evolution of the semiconductor chip
technology.
Maybe just help investors understand the design engineering team and the prowess that it has because that's, it's an impressive accomplishment
to get to iQ3 to begin with, but then to push it out and ultimately to get to P5 and then X and then within just a couple of years. So we just help
the investors understand their background, the prowess, and how confident you are that you guys will get to P5 and X.
Question: Josh Jennings - TD Securities LLC - Analyst
: And just on the relations with the Taiwanese Semiconductor Manufacturing Company, I mean one of the advantages that we've seen historically
was during the pandemic and then following the supply chain crisis predicted with semiconductor chips, Butterfly was not exposed to that because
of the exclusive agreement.
Maybe just help us think about how that agreement, the tail of it. And just in any capacity can change my assumption, I think the answer is no,
there aren't any because this agreement, but just walk us through how solid that agreement is and how just build on your last chance in terms of
why that's so impactful to the path forward for Butterfly.
Question: Josh Jennings - TD Securities LLC - Analyst
: Great, and just on the -- and we were fortunate to have Nevada join us at our Future Health Conference last fall, and he helped us kind of understand
how well Butterfly is positioned in terms of this developing AI algorithms because of the Butterfly Cloud, 20,000 images uploaded per day. Maybe
just help us, give us more clarity on why that's such a big advantage relative to the rest of the ultra-handheld ultrasound competitors that are out
there.
Question: Josh Jennings - TD Securities LLC - Analyst
: So I think we've seen Moore's law in effect with the image quality improvements in the processing power of P41 within iQ3 and just looking at the
images that you showed that were powered by P5 super impressive, very seemed maybe even better than the car-based system that you from
that you compared it to. As P5 continues in its development, is it possible that that image quality that you showed today gets even better before
you launch the NextGen or iQ4? So, It might be a hard question to answer.
REFINITIV STREETEVENTS | www.refinitiv.com | Contact Us
consent of Refinitiv. 'Refinitiv' and the Refinitiv logo are registered trademarks of Refinitiv and its affiliated companies.
MARCH 03, 2025 / 6:10PM, BFLY.N - Butterfly Network Inc at TD Cowen Healthcare Conference
Question: Josh Jennings - TD Securities LLC - Analyst
: Excellent. Well, I think we see the red light flash here, so we're going to end here. But Heather, thank you so much for joining us this year again,
and looking forward to tracking Butterfly's progress, throughout this year.
|
